1. Home
  2. WLK vs RDY Comparison

WLK vs RDY Comparison

Compare WLK & RDY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Westlake Corporation

WLK

Westlake Corporation

HOLD

Current Price

$103.13

Market Cap

12.8B

Sector

Industrials

ML Signal

HOLD

Logo Dr. Reddy's Laboratories Ltd

RDY

Dr. Reddy's Laboratories Ltd

HOLD

Current Price

$14.37

Market Cap

11.6B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
WLK
RDY
Founded
1986
1984
Country
United States
India
Employees
N/A
N/A
Industry
Major Chemicals
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
12.8B
11.6B
IPO Year
2004
2001

Fundamental Metrics

Financial Performance
Metric
WLK
RDY
Price
$103.13
$14.37
Analyst Decision
Buy
Strong Buy
Analyst Count
15
1
Target Price
$98.33
$16.90
AVG Volume (30 Days)
1.3M
1.6M
Earning Date
05-26-2026
01-01-0001
Dividend Yield
2.01%
0.50%
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$11,170,000,000.00
N/A
Revenue This Year
$3.18
$7.50
Revenue Next Year
$4.41
$2.96
P/E Ratio
N/A
$18.67
Revenue Growth
N/A
N/A
52 Week Low
$56.33
$12.26
52 Week High
$113.51
$16.17

Technical Indicators

Market Signals
Indicator
WLK
RDY
Relative Strength Index (RSI) 57.80 54.75
Support Level $73.33 $14.20
Resistance Level $103.00 $14.66
Average True Range (ATR) 5.73 0.25
MACD -0.15 -0.04
Stochastic Oscillator 53.84 45.06

Price Performance

Historical Comparison
WLK
RDY

About WLK Westlake Corporation

Westlake Corp is a manufacturer and supplier of chemicals, polymers, and building products. Its Performance and Essential Materials segment offers a wide range of essential building blocks for making products utilized in everyday living, including olefins, vinyl chemicals, polyethylene, and epoxies. Its Housing and Infrastructure Products segment produces key finished goods for building products, pipe and fittings, and global compounds businesses.

About RDY Dr. Reddy's Laboratories Ltd

Dr. Reddy's is one of the largest generic drug manufacturers in the world. It has a significant presence in North America, a region that makes up roughly half of its generics sales, and it services India (about 20% of its generics sales), Russia (10%), and certain European and Latin American countries. Beyond simple generics, Dr. Reddy's also has a solid portfolio of injectables which make up 25% of its North America sales. In branded generic markets like India, Dr. Reddy's has established a compelling presence with its strong brand name and earned a top five spot in key therapeutic areas including oncology and gastroenterology. Dr. Reddy's also has an active pharmaceutical ingredient business that manufactures over 150 APIs and sells in over 75 countries.

Share on Social Networks: